Volitionrx (VNRX) Income towards Parent Company (2012 - 2026)
Volitionrx's (VNRX) quarterly Income towards Parent Company came in at $260595.0 in Q4 2025, down 49.54% YoY from $516444.0 in Q4 2024, and up 929.05% on a QoQ basis from -$31433.0 in Q3 2025.
Volitionrx (VNRX) Income towards Parent Company (2012 - 2026) Analysis & Trends
Volitionrx (VNRX) has 10 years of Income towards Parent Company data on file, last reported at $260595.0 in Q4 2025.
- Quarterly Income towards Parent Company fell 49.54% year-over-year to $260595.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 31.64% YoY) and the FY2025 annual result came in at $146302.0, down 49.58% from the prior year.
- Income towards Parent Company advanced to $260595.0 in Q4 2025, from -$31433.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $516444.0 in Q4 2024 to a low of -$10.1 million in Q2 2023.
- A 5-year average of -$4.1 million and a median of -$3.0 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2021 — Income towards Parent Company plunged 88751.34% — and 2022, when it surged 791.1%.
- Tracing VNRX's Income towards Parent Company over 5 years: stood at -$8.0 million in 2021, then gained by 9.87% to -$7.2 million in 2022, then retreated by 21.38% to -$8.8 million in 2023, then surged by 105.88% to $516444.0 in 2024, then sank by 49.54% to $260595.0 in 2025.
- The last three Income towards Parent Company figures came in at $260595.0 (Q4 2025), -$31433.0 (Q3 2025), and $29992.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Volitionrx | 1.21 Mn | -1.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.90 Mn |
| Dec 31, 2025 | 260,595.00 |
| Sep 30, 2025 | -31,433.00 |
| Jun 30, 2025 | 29,992.00 |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | 516,444.00 |
| Sep 30, 2024 | -47,049.00 |
| Jun 30, 2024 | 74,629.00 |
| Mar 31, 2024 | -8.85 Mn |
| Dec 31, 2023 | -8.79 Mn |
| Sep 30, 2023 | -9.20 Mn |
| Jun 30, 2023 | -10.10 Mn |
| Mar 31, 2023 | -9.63 Mn |
| Dec 31, 2022 | -7.24 Mn |
| Sep 30, 2022 | -7.74 Mn |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | 83,977.00 |
| Dec 31, 2021 | -8.04 Mn |
| Sep 30, 2021 | -7.14 Mn |
| Jun 30, 2021 | 47,539.00 |